The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

This study has been completed.

Study NCT00063609 Information provided by Novartis

First Received: July 1, 2003 Last Updated: September 30, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	April 2005
Estimated Primary Completion Date:	No date given